Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Heffner

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|June 6, 1997
Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonistsS A Glase, H C Akunne, L M Georgic, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effectsL T Meltzer, C L Christoffersen, A E Corbin, et al.
Neuropharmacology|January 1, 1997
The pharmacology of the novel and selective sigma ligand, PD 144418H C Akunne, S Z Whetzel, J N Wiley, et al.
Journal of Medicinal Chemistry|December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Peptides|January 1, 1995
Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonistsT A Pugsley, H C Akunne, S Z Whetzel, et al.
Journal of Medicinal Chemistry|January 17, 1997
3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonistsD J Wustrow, W J Smith, A E Corbin, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Biochemical Pharmacology|April 18, 1995
Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1)H C Akunne, S B Demattos, S Z Whetzel, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|June 6, 1997
Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonistsS A Glase, H C Akunne, L M Georgic, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effectsL T Meltzer, C L Christoffersen, A E Corbin, et al.
Neuropharmacology|January 1, 1997
The pharmacology of the novel and selective sigma ligand, PD 144418H C Akunne, S Z Whetzel, J N Wiley, et al.
Journal of Medicinal Chemistry|December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Peptides|January 1, 1995
Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonistsT A Pugsley, H C Akunne, S Z Whetzel, et al.
Journal of Medicinal Chemistry|January 17, 1997
3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonistsD J Wustrow, W J Smith, A E Corbin, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Biochemical Pharmacology|April 18, 1995
Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1)H C Akunne, S B Demattos, S Z Whetzel, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Pageof 7